Welcome to our dedicated page for DiagnaMed Holdings news (Ticker: DGNMF), a resource for investors and traders seeking the latest updates and insights on DiagnaMed Holdings stock.
DiagnaMed Holdings Corp. (CSE: DMED, OTCQB: DGNMF) issues frequent news updates about its activities as a Canadian technology company focused on advanced natural hydrogen extraction technologies and clean tech applications. Its announcements highlight exploration programs, project acquisitions, community partnerships, and corporate developments linked to the natural hydrogen sector.
Recent news releases describe DiagnaMed’s work in the Ontario-Québec hydrogen corridor, including soil-gas surveys in the Témiscamingue/Timiskaming Graben conducted with Québec Innovative Materials Corp. (QIMC) and the Institut National de la Recherche Scientifique (INRS). These updates report hydrogen anomalies, extensions of a natural hydrogen system, and the use of a geological exploration model that the Company associates with natural hydrogen generation and migration.
Other disclosures cover the Company’s acquisition agreement for the Colchester East Natural Hydrogen Project in Nova Scotia, which DiagnaMed states consists of 30 licenses totaling 2,104 claims. News items also discuss a Memorandum of Understanding with the Témiscamingue First Nation and QIMC to advance natural hydrogen development along the Ontario-Québec hydrogen corridor, emphasizing environmental stewardship, Indigenous participation, and community engagement.
In addition, DiagnaMed’s news flow includes governance and capital markets updates, such as leadership appointments, equity incentive grants, and the engagement of a market-making firm. Investors and observers can use the DiagnaMed news feed on Stock Titan to follow exploration milestones, partnership announcements, and strategic steps the Company reports as it advances its natural hydrogen and clean tech initiatives.
DiagnaMed (OTCQB: DGNMF) entered an agreement to acquire the Colchester East Natural Hydrogen Project in Nova Scotia, comprising 30 licenses totalling 2,104 claims. The acquisition places DiagnaMed in a highly active natural hydrogen corridor adjacent to claims held by major players and complements its Ontario land position.
Deal terms include a $10,000 non-refundable cash payment, issuance of 10,000,000 common shares to sellers, a 2.0% royalty on hydrogen/mineral revenues and a repurchase option to buy back 50% of the royalty for $2,000,000. Transaction is subject to CSE approval and standard hold periods. DiagnaMed also appointed Fabrice Consalvo to its board to bolster energy expertise.
DiagnaMed (OTCQB: DGNMF) and QIMC reported new soil-gas results confirming a >11 km northward extension of the natural hydrogen system in Ontario's Témiscamingue Graben.
Across 454 samples on Lines 5–8 (45.3 km, 454 stations) the survey found 251 samples >500 ppm H2, 116 >1,000 ppm, 19 >2,000 ppm, and a peak of 2,817 ppm. The study area spans ~11.3 km N–S and 23 km E–W (~260 km²). Median H2 in the graben is 375 ppm versus 50–125 ppm in Abitibi sites; methane was detected in <3% of samples and average CO2 was 0.6%.
DiagnaMed (OTCQB: DGNMF) and QIMC announced a major natural hydrogen discovery in Ontario's Témiscamingue Graben on October 14, 2025. Of 456 soil-gas samples from four survey lines (July 8–21, 2025), 209 exceeded 500 ppm H2, with an average of 558 ppm and multiple peaks above 2,000 ppm. Anomalies align with deep faults beneath Quaternary sediments, supporting regional hydrogen migration. The program was run under INRS technical direction. An MOU with Témiscamingue First Nation was signed. Next steps include more survey lines, AMT/magnetic and radon-thoron mapping, and preliminary drilling site selection for 2026.
DiagnaMed (CSE: DMED / OTCQB: DGNMF) signed a Memorandum of Understanding on October 8, 2025 with Quebec Innovative Materials (CSE: QIMC) and Témiscamingue First Nation (TFN) to advance natural hydrogen development along the Ontario‑Quebec hydrogen corridor near Lake Témiscamingue.
The MOU creates a framework for cooperation emphasizing environmental stewardship, integration of Aboriginal Traditional Knowledge, economic participation for TFN members, in‑kind support for community projects, and quarterly progress meetings.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) has announced key leadership appointments and provided an update on its natural hydrogen exploration program. The company has appointed André Turmel as Executive Chairman and Pam Sangster as Strategic Advisor.
The company has completed an extensive hydrogen soil sampling program in Ontario's Témiscamingue Graben, collecting over 1,000 soil-gas samples in collaboration with Quebec Innovative Materials Corp. (QIMC) and Institut National de la Recherche Scientifique (INRS). Results from this flagship program are expected to be released in the coming weeks.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) announced two significant developments in its clean natural hydrogen initiatives. First, the company congratulated its partner Québec Innovative Materials Corp. (QIMC) on receiving a drill permit from the Quebec Government, validating their innovative exploration methods developed with INRS.
Additionally, DiagnaMed reported substantial progress in its Northern Ontario soil sampling program, completing 5 of 11 planned sampling lines with over 500 soil samples collected. The company's Ontario properties are strategically located on the geological continuation of QIMC's St-Bruno-de-Guigues assets, suggesting significant potential for clean natural hydrogen development.
DiagnaMed Holdings (OTCQB: DGNMF) has announced the issuance of equity incentives to align leadership interests with shareholders. The company granted 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants.
The stock options have an exercise price of $0.05 per share with a three-year exercise period. The grants support DiagnaMed's advancement of natural hydrogen projects in Ontario, conducted in collaboration with INRS and QIMC partners, including ongoing deployment in Northern Ontario.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) announced a leadership transition in its financial department. Jing Peng has stepped down from his position as Chief Financial Officer, effective immediately. The company has appointed Edward Low as Interim CFO, who brings significant experience in corporate finance and accounting for public companies.
Mr. Low will oversee DiagnaMed's financial operations during the transition period while the Board evaluates long-term leadership options. The company continues to focus on its hydrogen development initiatives and operational execution, particularly in Northern Ontario through its QIMC and INRS teams.
DiagnaMed Holdings Corp. (CSE: DMED) has launched a major hydrogen exploration campaign in Ontario in partnership with INRS and Quebec Innovative Materials Corp. The initiative will implement over 2,000 soil gas samples to identify high-potential natural hydrogen zones, replicating INRS-QIMC's successful exploration model from Quebec.
The exploration will be led by Dr. Marc Richer-Laflèche in collaboration with Temiscamingue First Nations. The program aims to leverage the proven geological model that demonstrated high hydrogen measurements and fault-controlled advection in Quebec. Additionally, the company announced the appointment of André Turmel to its Board of Directors, while Carlo Sansalone has stepped down.